We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Audentes Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 186 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 188 → 0 (-188)

100% less funds holding in top 10

Funds holding in top 10: 19 → 0 (-19)

100% less capital invested

Capital invested by funds: $2.57B → $0 (-$2.57B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 186

Holders
–
Holders Change
-188
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
186
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$220M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$193M
3
MF
Magnetar Financial
Illinois
-$95.4M
4
AAM
Alpine Associates Management
Florida
-$87.1M
5
AA
AQR Arbitrage
Connecticut
-$81.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
101
Polar Asset Management Partners
Ontario, Canada
– -$2.69M -45,000 Closed
WRBC
102
W.R. Berkley Corp
Connecticut
– -$2.62M -43,800 Closed
New York State Common Retirement Fund
103
New York State Common Retirement Fund
New York
– -$2.42M -40,400 Closed
PP
104
PDT Partners
New York
– -$2.41M -40,308 Closed
BNP Paribas Financial Markets
105
BNP Paribas Financial Markets
France
– -$2.26M -37,810 Closed
Voloridge Investment Management
106
Voloridge Investment Management
Florida
– -$2.23M -37,355 Closed
SCM
107
Stevens Capital Management
Pennsylvania
– -$2.1M -35,046 Closed
CC
108
Centiva Capital
New York
– -$2.09M -35,000 Closed
VI
109
Vestcor Inc
New Brunswick, Canada
– -$2.09M -35,000 Closed
UBS AM
110
UBS AM
Illinois
– -$2.08M -34,753 Closed
Deutsche Bank
111
Deutsche Bank
Germany
– -$1.98M -33,155 Closed
AC
112
Athanor Capital
New York
– -$1.79M -30,000 Closed
DCM
113
Dupont Capital Management
Delaware
– -$1.73M -28,900 Closed
AIG
114
American International Group
New York
– -$1.69M -28,177 Closed
TOPU
115
Trustees of Princeton University
New Jersey
– -$1.65M -27,522 Closed
Walleye Capital
116
Walleye Capital
New York
– -$1.63M -27,310 Closed
Manulife (Manufacturers Life Insurance)
117
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1.62M -27,113 Closed
HA
118
Havens Advisors
New York
– -$1.59M -26,572 Closed
AQR Capital Management
119
AQR Capital Management
Connecticut
– -$1.55M -25,973 Closed
KPF
120
K2 Principal Fund
Ontario, Canada
– -$1.54M -25,680 Closed
GCL
121
Glazer Capital LLC
New York
– -$1.5M -25,000 Closed
GI
122
GAMCO Investors
Connecticut
– -$1.49M -24,893 Closed
EVM
123
Eaton Vance Management
Massachusetts
– -$1.44M -24,000 Closed
VOYA Investment Management
124
VOYA Investment Management
Georgia
– -$1.34M -22,329 Closed
HM
125
Harvest Management
New York
– -$1.34M -22,326 Closed
3 4
5
6 7

BOLD Hedge Fund Activity: Q1 2020 in Review

0 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q1 2020, worth a combined $0 — down 100% from $2.57B a quarter earlier.

Sellers outnumbered buyers: 186 funds closed out of BOLD and 0 opened new positions — a net loss of 186 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $220M sold.

  • 0 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q1 2020, down from 188 in Q4 2019.
  • Funds reported $0 of Audentes Therapeutics, Inc stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Audentes Therapeutics, Inc positions in Q1 2020 and 186 closed out, a net change of -186 holders.
  • The largest Audentes Therapeutics, Inc seller in Q1 2020 was BlackRock, an estimated $220M sold.

Based on aggregated 13F filings for Q1 2020.